Increased metabolic potential, efficacy, and safety of emerging treatments in schizophrenia
JM Meyer, CU Correll - CNS drugs, 2023 - Springer
Patients with schizophrenia experience a broad range of detrimental health outcomes
resulting from illness severity, heterogeneity of disease, lifestyle behaviors, and adverse …
resulting from illness severity, heterogeneity of disease, lifestyle behaviors, and adverse …
[HTML][HTML] Efficacy and safety of esmethadone (REL-1017) in patients with major depressive disorder and inadequate response to standard antidepressants: a phase 3 …
Objective: To test esmethadone (REL-1017) as adjunctive treatment in patients with major
depressive disorder (MDD) and inadequate response to standard antidepressants. Methods …
depressive disorder (MDD) and inadequate response to standard antidepressants. Methods …
Pharmacological treatment of generalised anxiety disorder: current practice and future directions
HA Fagan, DS Baldwin - Expert Review of Neurotherapeutics, 2023 - Taylor & Francis
ABSTRACT Introduction Generalized Anxiety Disorder (GAD) is a common psychiatric
condition, characterized by the presence of general apprehensiveness and excessive worry …
condition, characterized by the presence of general apprehensiveness and excessive worry …
New developments in the treatment of schizophrenia: an expert roundtable
JT Kantrowitz, CU Correll, R Jain… - International Journal of …, 2023 - academic.oup.com
Background Schizophrenia is a disabling disorder that profoundly affects functioning and
quality of life. While available antipsychotics have improved outcomes for patients with …
quality of life. While available antipsychotics have improved outcomes for patients with …
Psychosis superspectrum II: neurobiology, treatment, and implications
Alternatives to traditional categorical diagnoses have been proposed to improve the validity
and utility of psychiatric nosology. This paper continues the companion review of an …
and utility of psychiatric nosology. This paper continues the companion review of an …
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges
PM Haddad, CU Correll - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
Introduction Maintenance antipsychotic treatment improves multiple outcomes in people with
schizophrenia. These benefits are challenged by medication nonadherence, which is a …
schizophrenia. These benefits are challenged by medication nonadherence, which is a …
Targeting metaplasticity mechanisms to promote sustained antidepressant actions
The discovery that subanesthetic doses of (R, S)-ketamine (ketamine) and (S)-ketamine
(esketamine) rapidly induce antidepressant effects and promote sustained actions following …
(esketamine) rapidly induce antidepressant effects and promote sustained actions following …
Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation …
RS McIntyre - Expert Opinion on Drug Safety, 2023 - Taylor & Francis
The moniker “psychedelic” was coined in 1956 by the British Psychiatrist, Humphrey
Osmond, referring to “mind manifesting.” Clinically, mind manifesting referred to a subjective …
Osmond, referring to “mind manifesting.” Clinically, mind manifesting referred to a subjective …
New trends in personalized treatment of depression
G Sampogna, C Toni, P Catapano… - Current Opinion in …, 2024 - journals.lww.com
Depression is a heterogeneous, complex and multidimensional disorder, representing one
of the leading causes of disability worldwide. The final aim of the management of patients is …
of the leading causes of disability worldwide. The final aim of the management of patients is …